Levi & Korsinsky Helps Shareholders SueWallSt After Sable Offshore Corp. Stock Drops

NEW YORK, NY / ACCESS Newswire / August 13, 2025 / – SueWallSt: Class Action Filed Against Sable Offshore Corp. – Contact Levi & Korsinsky Got Rocked by Rocket? You’re Not Alone This lawsuit is on behalf of persons or entities who purchased or otherwise acquired publicly traded Sable Offshore securities between May 19, 2025 […]

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Redwire Corporation – RDW

NEW YORK CITY, NY / ACCESS Newswire / August 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Redwire Corporation ("Redwire" or the "Company") (NYSE:RDW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Redwire and certain of its officers and/or directors

GALIANO GOLD REPORTS SECOND QUARTER 2025 RESULTS

Galiano Gold Inc. (“Galiano” or the “Company”) (TSX: GAU) (NYSE American: GAU)is pleased to report its secondquarter (“Q2”) 2025 operating and financial results. Galiano owns a 90% interest in the Asanko Gold Mine (“AGM”) located on the Asankrangwa Gold Belt in the Republic of Ghana, West Africa. All financial information contained in this news release

Applied Therapeutics Reports Second Quarter 2025 Financial Results

(NasdaqGM:APLT), – CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD – Presented full 12-month clinical results and new topline data from INSPIRE Phase 2/3 trial of govorestat for the treatment of CMT-SORD at PNS 2025 Annual Meeting highlighting slowed progression of disease observed via

Applied Therapeutics Reports Second Quarter 2025 Financial Results

Applied Therapeutics Reports Second Quarter 2025 Financial Results GlobeNewswire August 13, 2025 – CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD – Presented full 12-month clinical results and new topline data from INSPIRE Phase 2/3 trial of govorestat for the treatment of CMT-SORD at

Nationally recognized workforce leader Tamara Atkinson to join Goodwill Central Texas executive teams

Goodwill Central Texas announced today that Tamara Atkinson, Workforce Solutions Capital Area's Chief Executive Officer since 2016, will join its executive team this fall to oversee workforce development. Effective Wednesday, Oct. 29, 2025, Atkinson will assume the role of Chief Impact Officer and President of Workforce Advancement Strategy, to further the organization's mission to transform

Bird Announces 2025 Second Quarter Results; Delivers Strong Margin Accretion and Record Backlog

(TSX:BDT), MISSISSAUGA, Ontario, Aug. 13, 2025 (GLOBE NEWSWIRE) — “Bird continues to execute on its 2025-2027 Strategic Plan, focusing on sectors that have long-term demand drivers, and maintaining a risk balanced and highly collaborative work program that will drive growth and continued margin accretion. Even though the Company's second quarter was impacted by temporary project

Scroll to Top